logo

Bicycle Therapeutics Plc ADR: Weathering Stock Market Storms with 1.04B Market Cap

PNC Stock

Bicycle Therapeutics Plc ADR’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $28.91 on 06/20/23 and a low of $12.54 for the same time frame on 11/13/23.

52-week price history of BCYC Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Bicycle Therapeutics Plc ADR’s current trading price is -15.29% away from its 52-week high, while its distance from the 52-week low is 95.30%. The stock’s price range during the 52-week period has remained between $12.54 and $28.91. In the Healthcare sector, the company’s shares saw a trading volume of around 0.5 million for the day, which was evidently higher than the average daily volume of 0.39 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Bicycle Therapeutics Plc ADR (BCYC) has experienced a quarterly rise of 38.05% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.04B and boasts a workforce of 284 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 20.22, with a change in price of +10.67. Similarly, Bicycle Therapeutics Plc ADR recorded 449,373 in trading volume during the last 100 days, posting a change of +77.21%.

Examining BCYC’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for BCYC stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.11.

BCYC Stock Stochastic Average

As of today, Bicycle Therapeutics Plc ADR’s raw stochastic average for the last 50 days stands at 74.28%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 65.60%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 25.89% and 12.02%, respectively.

BCYC Stock Price Performance Analysis

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant gain of 35.45% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 26.69%. Over the past 30 days, the price of BCYC has leaped by -0.24%. And in the last five days, it has surged by 8.84%.